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Abstract
Nutrition is an essential condition for physical, mental, and psycho-emotional 
growth for both children and adults. It is a major determinant of health and a key 
factor for the development of a country. Breastfeeding is a natural biological pro-
cess, essential for the development of the life of the newborn at least during the first 
six months by ensuring a nutritional contribution adapted to the needs of the latter. 
Thus, breast milk is the physiological and natural food best suited to the nutrition 
of the newborn. It contains several various components, which are biologically 
optimized for the infant. Cells are not a negligible component of breast milk. Breast 
milk is also a continuous source of commensal and beneficial bacteria, including 
lactic acid bacteria and bifidobacteria. It plays an important role in the initiation, 
development, and composition of the newborn’s gut microbiota, thanks to its pre-
and probiotic components. Current knowledge highlights the interdependent links 
between the components of breast milk, the ontogeny of intestinal functions, the 
development of the mucus intestinal immune system, colonization by the intestinal 
microbiota, and protection against pathogens. The quality of these interactions 
influences the health of the newborn in the short and long term.
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1. Introduction
Nutrition is an essential condition for physical, mental, and psycho-emotional 
growth for both children and adults. It is a major determinant of health and a key 
factor for the development of a country. Nutritional disorders hamper economic 
growth and perpetuate poverty through three factors: direct losses in productiv-
ity linked to poor physical condition, losses resulting from increased health care 
costs and indirect losses due to poor cognitive function and school failures (Global 
Strategy 2003 WHO / UNICEF, Moroccan Strategy 2011–2019 / UNICEF) [1, 2]. 
Furthermore, nutritional disorders are not only the result of food insecurity since 
children living in good conditions are subject to deficiency syndromes, such as ane-
mia, being under or overweight or even stunted growth (Report global malnutrition 
UNICEF, 2018) [3].
The global food strategy for infants and young children focuses on promoting 
appropriate infants and young children. Breastfeeding is the best way of providing 
ideal food for the growth and development of healthy infants.
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Poor feeding practices would be particularly due to lack of information on the 
benefits of breastfeeding and complementary feeding practices. Therefore, breast 
milk is the most suitable physiological and natural food for the nutrition of the 
newborn [4]. Breastfeeding is therefore a real global public health problem. Indeed, 
the World Health Organization (WHO) recommends exclusive breastfeeding for at 
least 6 months, giving the infant a good start in life [2]. Breast milk plays an impor-
tant role in the initiation, development and composition of the gut microbiota of 
the newborn, thanks to its pre- and probiotic components [5–7].
Breast milk is particularly important in cases of prematurity and pronounced 
low birth weight at term, as the child is at increased risk of infection, long-term 
health problems and death due to the immaturity and dysfunction of virtually 
all components of innate immunity [8]. At birth, newborns inherit part of their 
mother’s microbiota, but there is growing evidence that breastfeeding forges this 
microbiota in the infant’s gut [9, 10]. The establishment of the microbiota in the 
newborn is a critical period that has an impact on the overall state of his future 
health. The mode of colonization and the composition of the intestinal microbiota 
of the newborn vary depending on the lifestyle of the mother, the delivery route 
and environmental factors [11–13]. Children born prematurely have an intestinal 
dysbiosis that diminishes over time. It does not seem to be related to environmental 
factors but could be correlated to the length of gestation [14].
The aim of this chapter is to highlight the relationship between breastfeeding, 
the gut microbiota and the health of the newborn.
2. Human milk: composition and evolution
2.1 Human milk composition
Breastfeeding is a natural biological process, essential for the development of the 
life of the newborn at least during the first six months. Breastmilk provides all the 
calories and nutrients a child needs in the first few months of life and continues to 
provide half or more of the nutritional requirements in the second half of life, and 
up to one third in the second year. It promotes sensory and cognitive development 
and protects infants against infectious and chronic diseases [4, 15].
Human breast milk is a complex fluid made up of a number of diverse compo-
nents, which are biologically optimized for the infant and which change dynami-
cally between women (Figure 1) [16–19].
The beneficial health effects of human milk have been linked to the abundance 
of bioactive molecules present, including secretory antibodies, immune cells, anti-
microbial proteins like lactoferrin, CD14 and lysozyme, regulatory cytokines and 
oligosaccharides [17]. Proteins and lipids beyond their role in the nutritional supply 
and essential source of energy for the newborn, have antimicrobial and immu-
nomodulatory activities. Nucleotides are also beneficial for the development and 
maturation of the gastrointestinal tract, as well as for microbiota development and 
immune function. The immunoglobulins present in milk in the form of secretory 
IgA and secretory IgG provide initial immunity to the immature immune system of 
the newborn [17]. The indigestible oligosaccharides are not directly intended to feed 
the baby, but to nourish his intestinal bacteria [20]. Breast milk also includes short 
chain fatty acids (SCFAs) from the fermentation of indigestible foods which are a 
source of prebiotics for the breastfed infant [21].
In addition to the major components of water, carbohydrates, fats, proteins and 
micronutrients, breast milk is also a continuous source of non-bacterial cells and 
bacterial cells of maternal origin, which are beneficial to the newborn. Cells are not 
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a negligible component of breast milk because of their impact on the health of the 
newborn [22]. Epithelial cells and cellular debris of glandular origin and immune 
cells of blood origin (macrophages, lymphocytes and polymorphonuclear cells) are 
present in breast milk. Recent breakthroughs have shown that breast milk is much 
more heterogeneous and that it also contains stem cells [22]. Ten years ago, the 
microbiome of breast milk was characterized in which bacteria form an ecosystem 
of probiotics beneficial to the newborn [23]. These probiotics are involved in the 
digestion of nutrients including the metabolism of oligosaccharides, although their 
most likely role is the modulation of immunity [24].
The predominant bifidobacteria and lactobacilli constitute the natural micro-
biota, originating from the gastrointestinal tract of the mother via an enteromam-
mary cycle [5, 7, 25–30]. High throughput sequencing, by pushing back the limits 
imposed by the passage through microbial cultures, has allowed a more complete 
and faster characterization of the microbiota. In fact, metagenomics, a revolution-
ary approach to the genetic study of a complex sample, has made it possible to 
capture 90% of the diversity of the microbiota in breast milk. Bacteroides, Blautia, 
Faecalibacterium, Ruminococcus, Roseburia, Subdoligranulum, Enterococcus and 
Escherichia-Shigella, have been repeatedly detected in breast milk in different stud-
ies using molecular approaches based on the 16S rRNA gene [11, 29–32].
Breast milk is a natural source of nutrients, rich in various bioactive molecules. 
The Cells, both eukaryotic and prokaryotic, are an important component and also 
play a crucial role in the well-being of newborns.
2.2 Breast milk evolution
The major components of breast milk, namely water, micronutrients and 
macronutrients, change during lactation to meet the needs of the newborn, par-
ticularly in relation to the establishment of the newborn’s initial immunity and 
the development of the intestinal epithelium and central nervous system [33–36]. 
This composition of breast milk is required to constantly change depending on the 
needs and age of the baby, the time of breastfeeding or the beginning and end of 
breastfeeding and the period of breastfeeding [13, 37]. Indeed, between the 3rd and 
5th day, colostrum is produced, then transitional milk is produced over the follow-
ing 15 days and finally, mature milk is produced approximately 3 weeks to 1 month 
Figure 1. 
Schematic illustration of the different components of human breast milk.
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after the start of breastfeeding [38, 39]. This mature mother’s milk from the first 
month, rich in prebiotics and probiotics, ensures intestinal homeostasis. In addi-
tion, breastfeeding is an interactive process where the baby’s behavior can to some 
extent determine the composition of his food. The composition profile of breast 
milk is relatively stable around the world and varies only slightly depending on the 
lifestyle and diet of the mother [40]. SCFAs in breast milk, secondary metabolites 
whose role is crucial in modulating the immune system, the development of the 
intestinal epithelium and the intestinal barrier function of the newborn, evolve like 
the other components. Dai et al. [21], have shown that the concentrations of SCFAs 
are higher in mature milk as well as in milk from mothers of full-term infants than 
from mothers of preterm infants.
3. The newborn’s gut microbiota
3.1 First colonization
The newborn, considered sterile at birth, presents a beginning of colonization 
of the gut by the bacteria in the amniotic fluid, placenta, cord blood and meco-
nium [14, 41, 42]. The bacterial DNA detected in these different matrices comes 
mainly from commensal bacteria belonging to the phyla Firmicutes, Tenericutes, 
Proteobacteria, Bacteroidetes and Fusobacteria [43, 44].
Colonization at birth of the baby’s digestive tract by bacteria allows an incessant 
dialog to be established between microorganisms and all the newborn’s defenses. 
The immune system thus learns to recognize and differentiate between pathogenic 
and non-pathogenic bacteria and beneficial food proteins. However, it also learns 
to scale up its reactions. It is through this intensive training that a good balance 
between the different immune responses is achieved [45].
It is highly likely that babies are born with an initial bacterial composition from 
the maternal womb. This initial culture may change during pregnancy, which 
explains the difference in microbial diversity in newborns at birth [44]. This initial 
(fetal) colonization is likely to reorganize the intestinal epithelium to prepare the 
environment to receive the new colonizing bacteria at birth.
At birth, the genus Streptococcus, and particularly the species Streptococcus 
thermophilus, is among the first GIT colonizers as it has been detected in the stools 
and breast milk of infants [28, 46, 47]. Streptococcus thermophilus is able to induce 
differentiation of intestinal epithelial cells [48]. Indeed, work carried out on axenic 
rats inoculated with Streptococcus thermophilus has shown that this bacterial species 
undergoes a progressive adaptation in the gut to stabilize after 30 days. The main 
impact of Streptococcus thermophilus is to massively stimulate the glycolysis pathway, 
leading to lactate production in the cecum. In addition, expression studies showed 
overexpression of SLC16A1 and SLC5A8, monocarboxylic acid transporters, as well 
as p27 (kip1) a protein involved in cell cycle arrest. These results suggest that lactate 
could be a signal produced by Streptococcus thermophilus and modulating the colon 
epithelium development [48, 49].
3.2 Factors impacting the microbiota diversity
The establishment of the gut microbiota in newborns is a critical period that has 
an impact on the overall state of their future health. The microbiota at birth will be 
impacted by various environmental factors, the most important of which are mode 
of delivery, type of infant feeding, gestational age, infant hospitalization and infant 
antibiotic use. Infants born at term vaginally, at home and exclusively breastfed 
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appear to have healthy gut microbiota, with the highest levels of Bifidobacteria and 
the lowest levels of Clostridium difficile and Escherichia coli [11, 50].
Interdependencies have been demonstrated between breast milk components, 
ontogeny of gut function, development of the mucosal intestinal immune system, 
colonization by the gut microbiota and protection against pathogens [15]. Williams 
et al. have suggested complex microbial interactions between breastfeeding mothers 
and their infants and support the hypothesis that variation in the milk microbiome 
may influence the infant GI microbiome. In fact, the result of this work provides 
that infant oral, maternal oral, and milk microbial communities were predominated 
by Firmicutes; maternal feces by Firmicutes and Bacteroidetes; and infant feces was 
characterized by a relatively even distribution of Firmicutes, Bacteroidetes, and 
Proteobacteria. Regarding bacterial genera, the most abundant in milk and mater-
nal and infant oral samples was Streptococcus, whereas Bacteroides were predominant 
in maternal and infant fecal microbiomes [51]. Moreover, the ontological prediction 
study carried out by Nouadi et al. , revealed an interconnection between the breast 
milk microbiota and the microbiota of the full-term newborn. The exploitation of 
the bioinformatics tool in this study, helped to provide a new representation and 
interpretation of the interactions between genes differentially expressed in the 
host intestine induced by the microbiota. Subsequently, giving an overview of the 
global patterns of gene expression in the epithelial cells of term infants. This study 
found that IL1β, RELA, INS, IRS1 and NFKBIA (Core Network Proteins) are the 
major regulators of four important biological processes. These processes induced 
in the first few months of a newborns’ life have concerned intestinal development, 
effect of nutrition, and impact of other environmental exposures on the intestinal 
microbiota colonization. This study indicates the importance of these interactions 
in health homeostasis [52].
3.3 Role of SCFAs in intestinal development
Short-chain fatty acids, produced by fermenting anaerobic bacteria are second-
ary metabolites, found on the surface of the intestinal lumen; they act as signaling 
molecules transferring information between the microbiota and the immune 
system [53].
These organic acids have an aliphatic chain of 1 to 6 carbons. The most abun-
dant SCFAs in humans are acetic acid (C2: 0), propionic acid (C3: 0) and butyric 
acid (C4: 0). SCFAs are the precursors of long chain fatty acids. The production 
of SCFAs in the gastrointestinal tract is particularly dependent on the diet and the 
type of host microbiota [54]. SCFAs found in breast milk are an important source of 
energy as well as being essential for maturing the gastrointestinal tract [55, 56].
Acetic acid represents 50–60% of SCFAs, it is produced by the genera 
Bifidobacteria and Lactobacilli. Acetic acid plays many roles including the synthesis 
of cholesterol and fatty acids, lipogenesis, insulin sensitivity and pH regulation of 
the intestinal lumen [57–60]. Bacteroides, Firmicutes and Lachnospiraceae are the 
main intestinal bacteria producing propionic acid. Depending on the substrate, 
these bacteria can also produce butyric acid. Propionic acid is involved in several 
biological processes, including lipid metabolism, anti-inflammatory activity, 
and anti-cancer activity. Butyric acid is produced by the genera Faecalibacterium, 
Eubacterium rectale and Roseburia spp. [61]. The latter is the least abundant, but 
exhibits significant beneficial effects on energy metabolism and intestinal homeo-
stasis [62, 63]. Moreover, butyric acid plays a key role in the down regulation of 
pro-inflammatory effectors of lamina propria macrophages and determines the 
expression of cytokines in T cells [64, 65]. Effectively, it is involved in the activation 
and differentiation of a memory phenotype of CD8 + T lymphocytes [66].
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4. Prematurity and microbiota
4.1 Causes of prematurity
Prematurity is a syndrome that includes all the situations associated with the 
occurrence of a birth before 37 weeks of amenorrhea. It is classified according 
to gestational age, extremely premature (less than 28 weeks), very premature 
(between 28 and less than 32 weeks) and moderate premature (between 32 and less 
than 37 full weeks of gestation) [67, 68]. Preterm birth can result in adverse effects 
and even short-term neonatal mortality [69, 70]. The long-term health conse-
quences of prematurity throughout adulthood of infants is an increased risk of type 
2 diabetes, obesity, hypertension, asthma, anxiety, spectrum disorders autistic, 
cerebral palsy, epilepsy and cognitive impairment, heart disease, chronic renal 
failure, lung function abnormalities and neurocognitive disorders [71–78]. These 
effects can have a negative impact on health care costs, education as well as quality 
of life [79, 80].
During pregnancy, along with hormonal, metabolic and immune changes, the 
different ecosystems of the mother’s microbiome (vaginal, uterine, etc.) change. 
Indeed, the vaginal microbiota is less diverse and more stable, with an abundance 
of bacteria of the genus Lactobacillus [81]. Changes in the gut microbiota also 
appearing in late pregnancy may help support the increased energy requirements 
needed for fetal development [82]. All these observations thus suggest a real role 
of the microbiota in the physiology of pregnancy. The occurrence of premature 
rupture and preterm of membranes was preceded in one-third of cases by deple-
tion of Lactobacillus, protective bacteria in the vaginal flora [83]. Dysbiosis could 
therefore play a role as a biomarker associated with pathology, but also be directly 
involved in pathophysiological processes. Indeed, vaginal dysbiosis could initiate 
an inflammatory cascade leading to prematurity. A modification of the vaginal 
microbiota, with a decrease in protective Lactobacillus, allows pathogens such as 
Gardnerella vaginalis or Mycoplasma hominis to proliferate [84] (Figure 2). These 
pathogens could then pass through the cervix and contaminate the chorio-decidual 
space. In the face of this aggression, an increased production of inflammatory 
cytokines, as a result of the immune response, would stimulate the recruitment 
of neutrophils, the production of prostaglandins and the synthesis of metal-
loproteinases [85]. This cascade of events would promote uterine contractility, 
shortening of the cervix, weakening of the fetal membranes and could lead to 
premature delivery [86]. The sequelae due to the exposure of the preterm newborn 
to an intrauterine inflammatory environment will accumulate with those of its 
developmental immaturity, which may result in early and severe neonatal disor-
ders, such as necrotizing enterocolitis (NEC), cystic periventricular leukomalacia 
or bronchopulmonary dysplasia [87]. Maternal dysbiosis will influence the initial 
fetal culture and consequently the colonization at birth of the gut microbiota in the 
preterm infant.
Also, when a newborn is born prematurely, it is necessarily separated from its 
mother for care reasons. This maternal separation and prematurity, responsible for 
dysbiosis, would increase the risk of developing pathologies [88].
Environmental factors, maternal microbes and breast milk shape healthy 
colonization of the infant gut. The colonizing microbes influence the development 
of the gut and also participate in several biological processes related to growth 
and survival. Several factors lead to dysbiosis in the gut microbiota of newborns, 
increasing the risk of neonatal conditions such as necrotizing enterocolitis and 
long-term health problems such as asthma, hypertension and obesity.
7
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4.2 Preterm intestinal microbiota
Premature infants may be admitted to a highly specialized area of the hospital, 
the Neonatal Intensive Care Unit (NICU). Prematurity and admission to the NICU 
are often unexpected and may occur before families have discussed the nature of 
feeding for their infants. Prenatal and postnatal exposure to antibiotics as well 
as other medical risks can affect the composition of the early gut microbiota in 
premature infants [89].
The immaturity of the intestine of preterm promotes pathogenic bacterial colo-
nization due to the high permeability of the intestinal surface, which paves the way 
for a destructive dysbiosis. This dysbiosis, responsible for chronic inflammation and 
microbial translocation across the weakened intestinal barrier, is associated with life-
threatening conditions of prematurity such as NEC and late-onset sepsis (LOS) [90].
Figure 2. 
Factors influencing microbial intestinal homeostasis of term and preterm infants.
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The intestinal microbiota of children born prematurely has a low diversity and 
a reduced number of anaerobic bacteria. Two elements which would participate in 
the risk of developing pathologies of premature babies. In premature newborns, it 
was observed a significant delay in colonization compared to full-term infants as 
well as colonization by a smaller number of bacterial species [91].
The delay in colonization is especially marked for the anaerobic flora 
(Bifidobacterium and Bacteroides) while the aerobic flora (Enterobacteriaceae, 
Enterococci, Staphylococci) colonizes the premature baby fairly quickly [92–102]. 
This delay in implantation may be due to the fact that these children are more 
frequently born by cesarean section, are quickly separated from their mothers and 
placed in a highly aseptic intensive care environment and often subjected to broad-
spectrum antibiotic therapy [89]. Several studies have compared the microbiota 
of NICU-cared preterm infants and healthy term infants after birth. A significant 
abundance of Staphylococcaceae has been observed in premature infants. In contrast, 
the abundance of Enterobacteriaceae, Streptococcaceae and Enterococcaceae is 
significantly lower in NICU preterm infants immediately after birth, and their level 
gradually increases from the 2nd week. The abundance of Bifidobacteriaceae in term 
newborns is greater than in preterms at birth, associated with a high concentration of 
acetate, a sign of good host health. However, higher levels of propionate and butyrate 
are noted in preterm infants, indicating less saccharolytic fermentation [103–105].
4.3 Breastfeeding in the intensive care unit: a way to support preterm infants
Breastfeeding in preterm infants is often initiated by administration through a 
nasogastric or orogastric probe. Infants switch to oral feeding when the coordina-
tion of sucking, swallowing and breathing is developed [106–108]. This oral feeding 
is a difficult stage for preterm infants [109], with almost 40% finding it difficult to 
transition to direct oral breastfeeding [110–113]. Olfactory stimulation [114–120], 
could remedy the difficulties of direct oral feeding and consequently reduce the 
risks of pathologies associated with prematurity [121, 122]. The results of several 
studies have shown that direct breastfeeding increases the likelihood of maintaining 
longer breastfeeding durations during NICU hospitalization and up to 4 months 
after discharge [93–95, 123–125].
In preterm infants, breast milk is associated with a significant reduction in NEC, 
and a reduction in other key morbidities, as well as improved neurodevelopmental 
outcomes [91]. These impacts have long-term benefits for the child (and mother) 
even after weaning. This advantage is probably due, in part, to the development 
of a healthy gut microbiota dominated by Bifidobacterium from breast milk and its 
bioactive components [126].
Breast milk could be a natural way to restore intestinal homeostasis newborn 
and meet the recommended health standards for newborn term and preterm [127]. 
Thus, awareness of the importance of breast milk for premature infants is essential 
for families whose premature birth is planned and for those whose child is in the 
NICU [128–132]. On the other hand, trained NICU personnel will help and encour-
age mothers to breastfeed more frequently during hospitalization. This breast milk 
and intestinal microbiota axis opens up promising research avenues for new thera-
pies in premature babies and other high-risk infants.
5. Conclusion
The long-term health of the human being is programmed before birth where 
nutrition plays a crucial role. Indeed, the mother’s lifestyle is a determining factor 
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in shaping her own microbiota, which will be transmitted in part to the fetus. From 
the moment of birth, breast milk is the optimal source of nutrition for the newborn, 
which will meet its nutritional and immune needs. It is recommended to be the only 
source of nutrition for the first six months of life and up to 2 years.
Preterm birth is a complex syndrome, the leading cause of morbidity and peri-
natal mortality. The immaturity of the preterm gastrointestinal tract and the initial 
dysbiosis are corrected by breastfeeding. Indeed, breast milk promotes an evolu-
tionary dynamic of the intestinal microbiota and is truly a food for all newborns 
and particularly premature babies in intensive care. The cross-talk established 
between the bioactive components of milk, mainly the metabolites of the intestinal 
microbiota and the intestinal mucosa of the newborn, can compensate for the delay 
in colonization in preterm infants. This infant’s breast milk-intestinal microbiota 
axis is a proven link between mother and baby. This symbiosis is essential for the 
maintenance of health and well-being.
Thus, promoting breastfeeding is the natural solution to preventing infant 
morbidity and mortality.
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